Poly Medicure Limited · NSE:POLYMED

Poly Medicure — Investor Presentation (August 2020)

35 slides from Poly Medicure's investor presentation, August 2020

  1. Slide 1: Uniquely positioned to deliver value and solutions beyond the device

    Uniquely positioned to deliver value and solutions “beyond the device.” August 2020 w w w. p o l y m e d i c u r e . c o m

  2. Slide 2: Content

    Content Polymed at a Glance Our Story Global Footprints Financial Snapshot Innovative and Winning Product Range R&D Capability Manufacturing Excellence Training, Education & Corporate Social Responsibility Responsible Manufacturer & Future Direction www.polymedicure.com Confidential

  3. Slide 3: Pursuit of Quality & Affordable Healthcare

    PURSUIT OF QUALITY INR 687 Crores & AFFORDABLE HEALTHCARE Consolidated Annual Turnover Poly Medicure Ltd is one of the leading 130+ Medical Devices medical devices manufacturer and exporter in India with a dominant position in medical 110+ consumables market with the focus on Countries Presence Inno

  4. Slide 4: Innovation, an Integral Part of Polymed Story

    Amongst the Top 5 I.V. Cannula Manufacturer in the world INNOVATION, AN INTEGRAL PART OF POLYMED STORY In India 1st Indigenous Dialyzer Manufacturer Creating value by developing innovative In India 275+ 5500+ healthcare products, which are Safe for Sales Associates Hospitals Reach medical community

  5. Slide 5: Vision, Mission, Values

    Vision Serve people through innovative health care solutions Mission We create value for our stakeholders by providing patient centric Medical Technology for a healthier world Values • Integrity • Ownership • Care • Learning • Inclusivity www.polymedicure.com Confidential

  6. Slide 6: India Medical Device Company of the Year 2018

    “India Medical Device Company of the Year 2018” Polymed awarded the prestigious honor as the India Medical Device Company of the Year by Department of Pharmaceuticals, Government of India on Feb 18, 2019. www.polymedicure.com Confidential

  7. Slide 7: Awards and Recognition

    Awards and Recognition Medical Device Company Top Exporter Award of the Year 2018 By PEC, Dept of Commerce, By DoP, Govt. of India Govt. of India Gold Award Star Performer Award By PHARMEXCIL for commendable contribution to By EEPC India regional award medical devices patents (Northern) for Export E

  8. Slide 8: Top 25 Industrial Innovative Company of the Year 2019

    Top 25 Industrial Innovative Company of the Year 2019 www.polymedicure.com Confidential

  9. Slide 9: Board of Directors & Management

    Board of Directors & Management Mr. Devendra Raj Mehta (Chairman, Non Executive Independent Director) Mr. Himanshu Baid Mr. Rishi Baid (Managing Director) (Joint Managing Director) Mr. Jugal Kishore Baid Mrs. Mukulika Baid Dr. Shailendra Raj Mehta (Non Executive Director) (Non Executive Director) (N

  10. Slide 10: Our Journey: Milestone achievements

    Our Journey…..…..Milestone achievements Commencement of Faridabad Plant-2 New Plant Company New R&D Acquired IMT Faridabad Manufacturing Operation Extension (100% EOU) Haridwar Listed in NSE Center Plan1Health, Italy Phase II 1997 2004 2007 2011 2016 2018 2019 2001 2002 2006 2009 2014 2018 2020 Expa

  11. Slide 11: Across the World, We Serve People in Over 110+ Countries

    10 Manufacturing Plants* (*2 under construction & ready by mid 2020) 1 R&D Center ACROSS THE WORLD, WE SERVE PEOPLE IN OVER www.polymedicure.com 110+ COUNTRIES Confidential

  12. Slide 12: Financial Snapshot

    Financial Snapshot Figures In INR Crore Net Consolidated Revenue Net Consolidated EBITDA 800 200 13.8% CAGR 10.5% CAGR 163.96 687.24 150 120.34 129.45 700 85.78 91.72 610.83 100 600 50 521.68 500 461.86 0 417.93 15-16 16-17 17-18 18-19 19-20 400 Net Consolidated PAT 120 300 14.7% CAGR 95.88 100 200

  13. Slide 13: Financial Snapshot

    Financial Snapshot Figures In INR Crore Net Profit Margin% Market Capitalisation* 3000 16 14.00% 2505.20 14 13.39% 2500 2272.72 11.74% 12.23% 2056.36 12 11.00% 1954.89 2000 10 1500 1252.38 8 6 1000 4 500 2 0 0 15-16 16-17 17-18 18-19 19-20 15-16 16-17 17-18 18-19 19-20 *RANK 398 (Market Cap NSE) as

  14. Slide 14: Leading Medical Technology and Innovative Solutions

    Leading Medical Technology and Innovative Solutions Comprehensive Product Range Our Growth Verticals Oncology Infusion & Vascular Access Vascular Access Renal Care Gastroentrology Critical Care Urology Anaesthesia & Blood Transfusion Diagnostic Respiratory Care Dialysis Surgery and Wound Drainage Bl

  15. Slide 15: Business Distribution – Products Category

    Business Distribution – Products Category 8% 3% 4% Infusion Therapy & Vascular Access -71% 5% Blood Transfusion - 9% Surgery & Wound Drainage - 5% 9% Renal - 4% Anaesthesia & Respiratory Range - 3% Others - 8% 71% www.polymedicure.com Confidential

  16. Slide 16: Addressing unmet needs in Vascular Access

    Addressing unmet needs in Vascular Access ▪ Short PIVC’s (Peripheral IV Cannula) ▪ Mini MID Lines ▪ MID Lines ▪ CVC (Central Venous Catheters) ▪ PICC (Peripherally Inserted Central Venous Catheters) ▪ PICC Ports www.polymedicure.com Confidential

  17. Slide 17: Our Patented Products

    Our Patented Products Arterial Cannula Safety Blood Safety I V Cannula Collection Set Safety Fistula Needle Our Patents Recognition Gold Award by PHARMEXCIL for commendable contribution to medical devices patents.

  18. Slide 18: Our Patented Products

    Our Patented Products Closed System Blood Safe I.V. Cannula I.V. Catheter Auto Air Stop Vial Access Spikes

  19. Slide 19: Our New Products

    Our New Products Pre-Filled Syringe Dialysis Machine Single use Dialyzer Face Shield Blood Collection Needle with VTM Kit PPE Kit N 95 Masks Flashback www.polymedicure.com Confidential

  20. Slide 20: R&D, Regulatory and Process Capabilities

    R&D, Regulatory and Process Capabilities ▪ R&D facility approved by the Ministry of Science & Technology, Government of India. ▪ All products are CE certified (EU Regulatory Compliant). www.polymedicure.com Confidential

  21. Slide 21: ISO Certification

    ISO Certification ▪ Best in Class facility and Processes www.polymedicure.com Confidential

  22. Slide 22: Manufacturing across four Countries

    Manufacturing across four Countries 1st Medical Device Company from India to have overseas plants. Faridabad Plant, India Haridwar Plant, India IMT Faridabad India Over 210+ Injection Moulding Machines & 800+ Injection Molds Faridabad Plant, India Jaipur Plant, India R & D Center, FBD, India More th

  23. Slide 23: Manufacturing Excellence

    Manufacturing Excellence Across four countries, we ensure our product maintains highest global standard. www.polymedicure.com Confidential

  24. Slide 24: Fully integrated from Product Design to Manufacturing

    Fully integrated from Product Design to Manufacturing PRODUCT Pro E/Creo DESIGN Solidworks Unigraphics MOLD DESIGN & Pro-E/Creo, PROCESS DEVELOP Mold Flow R&D Center, India 3-D Printing VMC TOOL & MACHINE Wire Cut MANUFACTURING CNC EDM Tooling Center, India www.polymedicure.com Confidential

  25. Slide 25: Industrial Capabilities at Polymed

    Industrial Capabilities at Polymed Volume Production Capacity HIGH GLOBAL • 3 .5 Million medical devices manufacturing capacity per day VOLUME Clean Room CLEAN ROOM • Total clean room area 125,000 square feet AVAILABLE IN INDIA FOR NEW PRODUCTS Highly Qualified Team TEAM WORKING FOR • Regulatory tea

  26. Slide 26: Industrial Capabilities at Polymed

    Industrial Capabilities at Polymed Development Orientation INFRASTRUCTURE FOR • R&D Team with 50+ engineers JOINT DEVELOPMENT • Process Engineering 30+ engineers AND TESTING • Ability to create molds internally Versatility in Solutions ABILITY TO MEET • Multiple technical solutions ANY NEED FROM • M

  27. Slide 27: Focus on Training & Continuous Medical Education

    Focus on Training & Continuous Medical Education www.polymedicure.com Confidential

  28. Slide 28: Focus on Training & Continuous Medical Education

    Focus on Training & Continuous Medical Education www.polymedicure.com Confidential

  29. Slide 29: Brand Communication Key Highlights – Social & Digital

    Brand Communication Key Highlights – Social & Digital 4 Sessions 8 Sessions Campaign on COVID Webinars 1,712 likes, 128 shares on social media platforms www.polymedicure.com Confidential

  30. Slide 30: Marketing Communication

    Marketing Communication Nursing Week Campaign World Kidney Day Campaign 10 creatives posted on social media Meet & Event Awareness Thanks Decor Greet Celebration Program Giving Successfully celebrated in 60+ Dialysis Centers PAN INDIA Touching 300+ technicians & 1200+ patients Personalized Greetings

  31. Slide 31: Corporate Social Responsibility

    Corporate Social Responsibility Supporting Education and Socio cultural activities for underprivileged children in various school. Promoting education for visually & mentally challenged children. Providing safe Drinking Water, Meals and Toilets for Girl Child in many schools. Supporting various NGOs

  32. Slide 32: Future Direction

    Future Direction Inorganic Growth ▪ Increase reach in key markets by Advance Global Reach inorganic route. ▪ Increase footprints in the developed countries. Expansion of Product Portfolio ▪ Expand manufacturing capabilities in new geographies. ▪ Expanding product basket in existing and newer therapy

  33. Slide 33: As We CARE

    As We CARE The obsession to become the best is what makes Polymed strive harder to reach its goals POLYMED For POLYMED For POLYMED for POLYMED for Healthcare Providers Patients Society & Sustainability Employees Providing high quality Providing access to quality We Integrate sustainability Safe and

  34. Slide 34: Thank You

    Poly Medicure Limited Thank You Registered Office: 232 B, 3rd Floor, Okhla Industrial Estate, Phase III, New Delhi-110020, India Tel:- 91-11-33550700, 47317000, 26321838/99 For any general queries, Reach us at: info@polymedicure.com Visit: www.polymedicure.com www.polymedicure.com Confidential

  35. Slide 35: Disclaimer

    DISCLAIMER This presentation has been prepared by Poly Medicure Limited (the “Company”) solely for your information and may not be distributed, reproduced, or redistributed or passed on directly or indirectly to any other person, whether within or outside your organization or firm, or published in w

Poly Medicure — Investor Presentation (August 2020) on 6ix